Our Approach & Programs

Metabolic diseases are extremely complex, with a number of biological and environmental factors at play.

We are developing treatments for a wide range of complex metabolic conditions where the MetAP2 pathway plays a central role. Our proprietary development platform, and insights into the unique characteristics of each disease, enable us to design a new class of MetAP2 therapies with tissue distribution characteristics tailored to the therapeutic need.